Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | LTK | P29376 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.33 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.33 |
| ▸ | CDK8 | P49336 | 1/20 | 0.33 |
| ▸ | CLK2 | P49760 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3109867 | 0.79 | GABRA1 (0.39) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| SCHEMBL3344111 | 0.76 | GABRA1 (0.37) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| Benzene SCHEMBL28085432 | 0.72 | GABRA1 (0.54) | GABRA1GABRB2KDM4EALDH1A1AURKA | |
| SCHEMBL28730875 | 0.72 | GABRA1 (0.42) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| SCHEMBL125206 | 0.72 | GABRA1 (0.42) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| SCHEMBL6841674 | 0.72 | GABRA1 (0.47) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| Hydrogen Peroxide SCHEMBL7819301 | 0.70 | GABRA1 (0.58) | GABRA1GABRB2KDM4EALDH1A1AURKA | |
| Hydrogen Peroxide SCHEMBL10784213 | 0.70 | GABRA1 (0.58) | GABRA1GABRB2KDM4EALDH1A1AURKA | |
| SCHEMBL173300 | 0.70 | GABRA1 (0.56) | GABRA1GABRB2KDM4EALDH1A1HTR1A | |
| SCHEMBL29763626 | 0.70 | GABRA1 (0.56) | GABRA1GABRB2KDM4EALDH1A1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | CARDOLITE CORPORATION (US) | 2020-12-29 | — | — | US | claimed |
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | CARDOLITE CORPORATION | 2019-03-14 | — | — | US | claimed |
| US-8110036-B2 | Moisture curable oil and fat compositions and processes for preparing the same | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERISTY (US) | 2012-02-07 | — | — | US | claimed |
| WO-2010042175-A1 | MOISTURE-CURABLE OIL AND FAT COMPOSITIONS AND PROCESSES FOR PREPARING THE SAME | MICHIGAN STATE UNIVERSITY (US) | 2010-04-15 | — | — | WO | claimed |
| US-20100083871-A1 | Moisture-curable oil and fat compositions and processes for preparing the same | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2010-04-08 | — | — | US | claimed |
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | CARDOLITE CORPORATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | CARDOLITE CORPORATION | 2019-03-14 | — | — | US | disclosed |
| EP-2994105-A2 | CONSUMER PRODUCTS COMPRISING SILANE-MODIFIED OILS | The Procter and Gamble Company (US) | 2016-03-16 | — | — | EP | disclosed |
| EP-2994106-A2 | CONSUMER PRODUCTS COMPRISING SILANE-MODIFIED OILS | The Procter and Gamble Company (US) | 2016-03-16 | — | — | EP | disclosed |
| EP-2994104-A2 | CONSUMER PRODUCTS COMPRISING SILANE-MODIFIED OILS | The Procter and Gamble Company (US) | 2016-03-16 | — | — | EP | disclosed |
| EP-2994103-A2 | CONSUMER PRODUCTS COMPRISING SILANE-MODIFIED OILS | The Procter & Gamble Company (US) | 2016-03-16 | — | — | EP | disclosed |
| EP-2994107-A2 | CONSUMER PRODUCTS COMPRISING SILANE-MODIFIED OILS | The Procter & Gamble Company (US) | 2016-03-16 | — | — | EP | disclosed |
| US-20140335035-A1 | Consumer Products Comprising Silane-Modified Oils | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-13 | — | — | US | disclosed |
| US-20140335032-A1 | Consumer Products Comprising Silane-Modified Oils | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-13 | — | — | US | disclosed |
| US-8110036-B2 | Moisture curable oil and fat compositions and processes for preparing the same | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERISTY (US) | 2012-02-07 | — | — | US | disclosed |
| WO-2010042175-A1 | MOISTURE-CURABLE OIL AND FAT COMPOSITIONS AND PROCESSES FOR PREPARING THE SAME | MICHIGAN STATE UNIVERSITY (US) | 2010-04-15 | — | — | WO | disclosed |
| US-20100083871-A1 | Moisture-curable oil and fat compositions and processes for preparing the same | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2010-04-08 | — | — | US | disclosed |
| US-4512926-A | Process for the silylation of unsaturated, naturally occurring oils or the interesterification products thereof | CHEMISCHE WERKE HUELS AG (DE) | 1985-04-23 | — | — | US | disclosed |
| US-4396751-A | Homo- and copolymers of 1,3-dienes containing reactive silyl groups, and their preparation and use | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DE) | 1983-08-02 | — | — | US | disclosed |
| US-4381377-A | Homo- or copolymers of 1,3-dienes carrying reactive silyl groups, their preparation and use | CHEMISCHE WERKE HUELS, AG (DE) | 1983-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077815-A1 | COMPOSITIONS, SYNTHESIS, AND USES OF HYDROLYZABLE SILANE MODIFIED CASHEW NUT SHELL LIQUID DERIVATIVES | NANS, SGMS1, FUT6 | GABRA1 4816/4885GABRB2 4867/4885KDM4E 2229/4885 |
| US-20140335035-A1 | Consumer Products Comprising Silane-Modified Oils | SGMS2, SCD, ELOVL1 | GABRA1 3143/4885GABRB2 3005/4885KDM4E 2192/4885 |
| US-10875879-B2 | Compositions, synthesis, and uses of hydrolyzable silane modified cashew nut shell liquid derivatives | NANS, SGMS1, FUT6 | GABRA1 4816/4885GABRB2 4867/4885KDM4E 2229/4885 |
| US-20140335032-A1 | Consumer Products Comprising Silane-Modified Oils | SGMS2, SGMS1, SCD | GABRA1 3297/4885GABRB2 3579/4885KDM4E 2582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.